Oxford Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Oxford Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-4,769,550	Closed	-$1.15M	–	984
2016 Q2	$1.15M	Sell	4,769,550 -250,000	-5%	-$43K	0.04%	458
2016 Q1	$572K	Hold	5,019,550	–	–	0.02%	592
2015 Q4	$532K	Hold	5,019,550	–	–	0.01%	660
2015 Q3	$955K	Hold	5,019,550	–	–	0.03%	411
2015 Q2	$3.51M	Hold	5,019,550	–	–	0.1%	237
2015 Q1	$3.4M	Buy	5,019,550 +1,500,000	+43%	+$1.05M	0.09%	265
2014 Q4	$2.82M	Buy	+3,519,550	New	+$2.4M	0.06%	306
2014 Q3	–	Sell	-1,845,471	Closed	-$904K	–	883
2014 Q2	$904K	Sell	1,845,471 -632,029	-26%	-$306K	0.03%	501
2014 Q1	$792K	Buy	2,477,500 +327,500	+15%	+$122K	0.02%	486
2013 Q4	$731K	Buy	+2,150,000	New	+$2.6M	0.02%	549

Other funds holding GCVRZ

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

BCM

Brigade Capital Management New York $534M AUM 44.37% 1-Year Est. Return

NGA

New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

GCM

Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

BHMP

Bardin Hill Management Partners New York $80.3M AUM 31.39% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Oxford Asset Management's GCVRZ Position: Q3 2016 in Review

Oxford Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2016, closing a stake of 4,769,550 shares — an estimated $1.15M sold.

Oxford Asset Management first reported a position in GCVRZ in Q4 2013 and held it in 10 quarters. The position peaked at $3.51M in Q2 2015. 117 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2016.

Oxford Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q3 2016 after selling out during the quarter.
Oxford Asset Management sold 4,769,550 Sanofi Contingent Value Rights shares in Q3 2016, an estimated $1.15M.
Oxford Asset Management first reported a position in Sanofi Contingent Value Rights in Q4 2013 and held it in 10 quarters.
Oxford Asset Management's Sanofi Contingent Value Rights position peaked at $3.51M in Q2 2015.
117 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2016.

Based on Oxford Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.